Credit Suisse’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,253
Closed -$28.3K 3754
2022
Q4
$28.3K Buy
3,253
+871
+37% +$19.2K ﹤0.01% 3446
2022
Q3
$68K Buy
2,382
+7
+0.3% +$320 ﹤0.01% 3502
2022
Q2
$98K Buy
2,375
+285
+14% +$19.3K ﹤0.01% 3535
2022
Q1
$212K Buy
2,090
+140
+7% +$15.6K ﹤0.01% 3354
2021
Q4
$287K Buy
+1,950
New +$436K ﹤0.01% 4133

Other funds holding WGS

Credit Suisse's WGS Position: Q1 2023 in Review

Credit Suisse sold out of GeneDx Holdings (WGS) in Q1 2023, closing a stake of 3,253 shares — an estimated $28.3K sold.

Credit Suisse first reported a position in WGS in Q4 2021 and held it in 5 quarters. The position peaked at $287K in Q4 2021. 82 funds tracked by Wall St. Rank hold WGS as of Q1 2023.

  • Credit Suisse reported no remaining GeneDx Holdings position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 3,253 GeneDx Holdings shares in Q1 2023, an estimated $28.3K.
  • Credit Suisse first reported a position in GeneDx Holdings in Q4 2021 and held it in 5 quarters.
  • Credit Suisse's GeneDx Holdings position peaked at $287K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.